Supportive care, or palliative care, in oncology patients has been a shifting paradigm in the last few years. Patients with... »
In the last decade, the development of imatinib, a tyrosine kinase inhibitor, has brought about unprecedented change in the... »
The number of breast cancer survivors in the United States is increasing. With longer survival, there has been an increase... »
When deciding whether or not chemotherapy is “futile,” the concept of medical futility must be explored.1 Though it remains... »
For many clinicians in oncology, educating other health-care professionals about cancer pain and palliative care is part of... »
Children are too often the forgotten mourners in the homes of dying patients. Children, even young children, and youth... »
Hospice programs provide comprehensive, compassionate care to dying patients and their families. However, many patients do... »
Caring for the “whole person” across the continuum of disease remains a top priority for clinicians. Strides in basic and... »
We are living in an era of “molecularly targeted therapy.” This targeted approach has developed as advances in science have... »
The Journal of Supportive Oncology Focused on symptom and side-effect management, communication issues, and end-of-life care for patients with cancer. For past issues, click here »